Potent benzimidazolone based human beta(3)-adrenergic receptor agonists

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Cardiovascular Research

Background:

• Beta(3) adrenergic receptors play a role in regulating heart rate and contractility.
• Benzimidazolone derivatives are explored for various therapeutic applications.
• Atrial tachycardia is a cardiac arrhythmia requiring effective treatment strategies.

Purpose of the Study:

• To synthesize and biologically evaluate novel benzimidazolone derivatives as beta(3) adrenergic receptor agonists.
• To investigate the structure-activity relationship of these compounds concerning their effect on cardiac function.
• To identify potential therapeutic agents for managing atrial tachycardia.

Main Methods:

• Chemical synthesis of a series of benzimidazolone compounds with varying substituents at the 3-position.
• In vitro and in vivo biological evaluation of synthesized compounds.
• Assessment of the compounds' effects on rat atrial tachycardia models.

Main Results:

• Successful synthesis of diverse benzimidazolone derivatives.
• Demonstrated agonist activity at beta(3) adrenergic receptors.
• Observed a trend of reduced rat atrial tachycardia with increased steric bulk at the 3-position of the benzimidazolone moiety.

Conclusions:

• The synthesized benzimidazolone derivatives show promise as beta(3) adrenergic receptor agonists.
• Steric bulk at the 3-position of the benzimidazolone core is a critical factor in modulating activity against atrial tachycardia.
• These findings provide a basis for the development of new anti-arrhythmic agents.